Product
Madopar
3 clinical trials
2 indications
Indication
Parkinson's diseaseIndication
HealthyClinical trial
A Randomized, Parallel Group, Multicenter, Prospective, Open-label, Exploratory, Phase 4 Study to Evaluate the Add-on Effect of Opicapone 50 mg or Levodopa 100 mg as First Strategy for the Treatment of Wearing-off in Patients With Parkinson's DiseaseStatus: Completed, Estimated PCD: 2022-08-18
Clinical trial
Clinical and Pharmacokinetics Study to Evaluate the Therapeutic Equivalence and Bioequivalence of Levodopa Benserazide Generic Formulation (Teva Italia) Versus the Originator (Madopar®)Status: Completed, Estimated PCD: 2015-12-01